You are searching for: hsa04510

---

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T40097 Target Info	Target Name	Stress-activated protein kinase JNK1 (JNK1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; T-cell leukaemia;
	Drugs	NKP-1339	Drug Info

T07303 Target Info	Target Name	Vascular endothelial growth factor receptor 3 (FLT-4)
	Target type	Successful Target
	Disease	Renal cell carcinoma; Vascular restinosis;
	Drugs	Tivozanib	Drug Info

T04902 Target Info	Target Name	Calpain-2 (CAPN2)
	Target type	Clinical trial Target
	Disease	Trematode infection; Neurological disorder;
	Drugs	ABT-957	Drug Info

T91696 Target Info	Target Name	Fibronectin (FN1)
	Target type	Clinical trial Target
	Disease	Symptomatic vitreomacular adhesion; Colorectal cancer;
	Drugs	Ocriplasmin	Drug Info

T15068 Target Info	Target Name	Focal adhesion kinase 1 (FAK)
	Target type	Clinical trial Target
	Disease	Ovarian cancer; Mesothelioma;
	Drugs	VS-6063	Drug Info

T83797 Target Info	Target Name	Hepatocyte growth factor (HGF)
	Target type	Clinical trial Target
	Disease	Angina pectoris; Peripheral arterial disease;
	Drugs	Donaperminogene seltoplasmid	Drug Info

T29879 Target Info	Target Name	Integrin alpha-5 (ITGA5)
	Target type	Clinical trial Target
	Disease	Macular degeneration; Allergic rhinitis;
	Drugs	JSM 6427	Drug Info

T67103 Target Info	Target Name	Integrin alpha-V (ITGAV)
	Target type	Clinical trial Target
	Disease	Colorectal cancer; Solid tumour/cancer;
	Drugs	Abituzumab	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.